Chromosome
3 minutes ago
JRoon, that is largely true as it takes time to develop the market. I would say statins bucked the trend. From my experience at AZ with Lokelma (hyperkalemia), success hinged on converting the market from acute, ambulatory setting to chronic use to keep potassium levels in range, the premise being t